Fischer Medical Ventures Ltd
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
- Market Cap ₹ 7,023 Cr.
- Current Price ₹ 108
- High / Low ₹ 125 / 60.0
- Stock P/E
- Book Value ₹ 5.26
- Dividend Yield 0.00 %
- ROCE 0.50 %
- ROE 0.32 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 20.4 times its book value
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.3.14 Cr.
- Company has high debtors of 1,194 days.
- Working capital days have increased from 597 days to 1,408 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.04 | 0.02 | 0.00 | 0.00 | -0.01 | -0.01 | 0.18 | 0.17 | 0.00 | 0.18 | 11.53 | 5.22 | 9.76 | |
0.11 | 0.08 | 0.12 | 0.14 | 0.19 | 0.17 | 0.20 | 0.19 | 0.19 | 0.16 | 11.72 | 7.46 | 11.51 | |
Operating Profit | -0.07 | -0.06 | -0.12 | -0.14 | -0.20 | -0.18 | -0.02 | -0.02 | -0.19 | 0.02 | -0.19 | -2.24 | -1.75 |
OPM % | -175.00% | -300.00% | -11.11% | -11.76% | 11.11% | -1.65% | -42.91% | -17.93% | |||||
0.07 | 0.09 | 0.09 | 0.07 | 0.20 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | 3.46 | 3.14 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.13 | 1.44 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.21 |
Profit before tax | 0.00 | 0.03 | -0.03 | -0.07 | 0.00 | 0.01 | -0.04 | -0.04 | -0.20 | 0.00 | 0.54 | 0.96 | -0.26 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -450.00% | 20.00% | 25.93% | 30.21% | ||||
0.00 | 0.03 | -0.03 | -0.07 | 0.00 | 0.00 | -0.04 | 0.14 | -0.23 | -0.04 | 0.40 | 0.66 | -0.79 | |
EPS in Rs | 0.00 | 0.01 | -0.01 | -0.02 | 0.00 | 0.00 | -0.24 | 0.82 | -1.35 | -0.24 | 0.01 | 0.01 | -0.01 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 48.33% |
Compounded Sales Growth | |
---|---|
10 Years: | 74% |
5 Years: | 96% |
3 Years: | % |
TTM: | -15% |
Compounded Profit Growth | |
---|---|
10 Years: | 36% |
5 Years: | 79% |
3 Years: | 70% |
TTM: | -154% |
Stock Price CAGR | |
---|---|
10 Years: | 78% |
5 Years: | 106% |
3 Years: | 112% |
1 Year: | 64% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.44 | 3.44 | 3.44 | 3.44 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 53.50 | 63.80 |
Reserves | -3.47 | -3.44 | -3.48 | -3.54 | -0.27 | -0.27 | -0.31 | -0.17 | -0.40 | -0.44 | 26.18 | 271.88 |
0.02 | 0.00 | 0.04 | 0.14 | 0.24 | 0.20 | 0.22 | 0.23 | 0.39 | 0.57 | 0.00 | 22.08 | |
0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.01 | 0.06 | 0.03 | 0.03 | 0.05 | 12.15 | 0.74 | |
Total Liabilities | 0.02 | 0.03 | 0.02 | 0.04 | 0.14 | 0.11 | 0.14 | 0.26 | 0.19 | 0.35 | 91.83 | 358.50 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.68 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.28 | 294.36 |
0.02 | 0.03 | 0.02 | 0.04 | 0.14 | 0.11 | 0.14 | 0.26 | 0.19 | 0.35 | 50.54 | 63.46 | |
Total Assets | 0.02 | 0.03 | 0.02 | 0.04 | 0.14 | 0.11 | 0.14 | 0.26 | 0.19 | 0.35 | 91.83 | 358.50 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.01 | 0.02 | -0.05 | -0.07 | -0.01 | 0.00 | 0.01 | -0.06 | -0.18 | -0.15 | 0.08 | -24.10 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -37.78 | -231.79 | |
-0.06 | -0.02 | 0.04 | 0.10 | 0.10 | -0.04 | 0.00 | 0.00 | 0.15 | 0.17 | 37.67 | 256.18 | |
Net Cash Flow | -0.07 | 0.00 | -0.01 | 0.03 | 0.09 | -0.03 | 0.01 | -0.06 | -0.03 | 0.02 | -0.03 | 0.28 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 344.72 | 402.04 | 1,194.29 | |||
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 5.63 | |||||||
Days Payable | 31.35 | |||||||||||
Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 344.72 | 402.04 | 1,168.56 | |||
Working Capital Days | -273.75 | -365.00 | 365.00 | 365.00 | -40.56 | 21.47 | -831.39 | 1,215.29 | 1,407.56 | |||
ROCE % | 0.00% | -350.00% | 0.00% | 8.33% | -22.22% | -12.90% | -97.44% | 8.70% | 1.40% | 0.50% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
2d - 32nd AGM (29 Sep 2025): adopted FY2025 financials; declared 0.5% dividend; reappointed director and auditors.
-
Closure of Trading Window
29 Sep - Trading window closed Oct 1, 2025 until 48 hours after unaudited Q2 results for September 30, 2025.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 29 Sep
-
Reg. 34 (1) Annual Report.
23 Sep - Corrigendum: Revised Annual Report FY2024-25 correcting ratios, equity, cash flows, related-party and note disclosures; revised report attached.
-
Dividend Clarification
16 Sep - Dividend adjusted to ₹0.005/share after 10→1 stock split; record dates Sept 12 and Sept 22, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Dec 2024TranscriptNotesPPT
Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals